NEED FOR GUIDELINE
The Standards of Care Committee of the British Thoracic Society (BTS) established a Pleural Disease Guideline Group in December 2007. The objective was to produce an evidence-based update of the last pleural disease guidelines published in 2003. It was recognised that, since the last guideline, a number of good quality primary research papers have been published and the guidelines needed to reflect these new data. In addition, there was a need to develop new sections on local anaesthetic thoracoscopy and thoracic ultrasound to reflect changes in clinical practice.
INTENDED USERS AND SCOPE OF THE GUIDELINE
This guideline is intended for use by all healthcare professionals who may be involved in pleural disease management. This will include doctors, nurses and other healthcare professionals.
AREAS COVERED BY THIS GUIDELINE
The guideline addresses the investigation and medical management of pleural disease in adults. This is divided into the following sections: 1. Investigation of a unilateral pleural effusion in adults. 2. Management of spontaneous pneumothorax. 3. Management of a malignant pleural effusion. 4. Management of pleural infection in adults. 5. Local anaesthetic thoracoscopy. 6. Chest drain insertion and thoracic ultrasound.
The six sections can be downloaded individually from the website. Key points are repeated within sections to give users a full review of the individual documents without the need to cross reference repeatedly. In addition, at the end of this section (Annex 1) there is a list of good areas for audit and future research.
AREAS NOT COVERED BY THIS GUIDELINE
The following areas fall outside the scope of this guideline: Scope of the guideline, PICOT questions and literature search
The guidelines are based upon the best available evidence. The methodology followed the criteria as set out by the Appraisal of Guidelines Research and Evaluation (AGREE) collaboration in the document the AGREE instrument available online at http://www.agreecollaboration.org/instrument/.
The scope and purpose of the guideline had been agreed and defined in consultation with all potential stakeholders representing the medical and nursing professions, patient groups, health management and industry (see full list of stakeholders at the end of this section).
Guideline members identified and formulated a set of key clinical questions in Population, Intervention, Comparison, Outcome, and Time (PICOT) format to inform the search strategies for the literature search.
The BTS commissioned the Centre for Reviews and Dissemination at the University of York to undertake a bespoke literature search using the search strategies shown in detail on the BTS website (http://www.brit-thoracic.org.uk). The following databases were searched: Ovid MEDLINE (from 1960 onwards) (including MEDLINE In Process), Ovid EMBASE, Cochrane Database of Systematic Reviews (CDRS), the Database of Abstracts of Reviews of Effects (DARE) The Guideline Committee agreed on the following criteria to select relevant abstracts for the guideline: 1. Studies that addressed the clinical question. 2. Appropriate study types used to produce the best evidence to answer the clinical question. 3. Non-English abstracts were not evaluated. 4. Abstracts were not rejected on the basis of the journal of publication, the country in which the research was done or published or the date of publication.
A total of 17 393 abstracts were rejected through the criteria outlined above and 2032 full papers were ordered for critical appraisal.
< Supplementary data are published online only. To view these files please visit the journal online (http://thorax.bmj. com).
Critical appraisal of the literature
A further 591 full papers were rejected because they fell outside the area of focus and scope of the guideline. Formal critical appraisal to assess the clinical relevance and scientific rigor of 1441 papers was performed independently by at least two guideline reviewers using the Scottish Intercollegiate Guidelines Network (SIGN) critical appraisal checklists (see online appendix 2). The guideline reviewers identified an additional 148 papers during the period of guideline development which were added and critically appraised. The evidence in each study was graded using the SIGN formulated levels of evidence (table 1) .
Considered judgement and grading of the evidence
Evidence tables were produced to review the body of evidence and inform the considered judgements and grading of recommendations. Where there was a lack of evidence, consensus statements were derived by incorporating a number of individual non-biased expert opinions from experts in the field.
The following were considered in grading of the recommendations: 1. The available volume of evidence. The revised draft guideline was submitted to the BTS Standards of Care Committee for review and published online for a month (in August 2009) to allow for BTS member and public consultation. All the feedback was reviewed and discussed by the Guideline Committee and incorporated into the revised draft guideline. The literature search was repeated by the Centre for Reviews and Dissemination and Centre for Health Economics at the University of York and additional evidence appraised and included in the final draft of the guideline.
PLANNED REVIEW OF THE GUIDELINE
The guideline will be reviewed and updated in 4 years from publication. 
GUIDELINE GROUP MEMBERSHIP

STAKEHOLDER ORGANISATIONS
The following organisations were identified as stakeholders and given the opportunity to comment on the draft documents 
1++
High quality meta-analyses, systematic reviews of randomised controlled trials (RCTs) or RCTs with a very low risk of bias 1+
Well conducted meta-analyses, systematic reviews of RCTs or RCTs with a low risk of bias 1 Meta-analyses, systematic reviews or RCTs or RCTs with a high risk of bias 2++
High quality systematic reviews of caseecontrol or cohort studies or high quality caseecontrol or cohort studies with a very low risk of confounding, bias or chance and a high probability that the relationship is causal 2+ Well conducted caseecontrol or cohort studies with a low risk of confounding, bias, or chance and a moderate probability that the relationship is causal 2
Caseecontrol or cohort studies with a high risk of confounding, bias or chance and a significant risk that the relationship is not causal 3
Non-analytical studiesdfor example, case reports, case series 4
Expert opinion 
